NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) today announced the launch of its innovative next-gen program, introducing advanced features designed to make weight management ...
Read MoreOSLO, Norway and BURLINGAME, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Accumulus Synergy’s innovative cloud-based data-sharing platform could accelerate access to vaccines and other health technologies by enabling multi-country regulatory ...
Read MoreBENGALURU, India, Dec. 10, 2024 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a pioneering Bengaluru-based biotechnology company, has successfully closed its seed funding round backed by angel investors. This funding will ...
Read MoreAIV001 is currently in development for evaluation in Superficial and Nodular Superficial Basal Cell Carcinoma (sBCC and nBCC) COSA MESA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, ...
Read MoreTURIN, Italy, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Technology has assumed an increasingly decisive role in social development and in all areas of human life, from education to work, from the environment to health. In order to investigate the ...
Read MorePR Newswire WASHINGTON, Dec. 11, 2024 WASHINGTON, Dec. 11, 2024 /PRNewswire/ -- Paragon Health Institute, a leader in healthcare research and market-based policy proposals, has released today a significant report on artificial intelligence ...
Read MorePR Newswire SAN DIEGO, Dec. 11, 2024 Research Demonstrates High Reliability and User Engagement with NeuroUX's Mobile Cognitive Tests SAN DIEGO, Dec. 11, 2024 /PRNewswire-PRWeb/ -- NeuroUX Inc., a leader in digital phenotyping tools, is ...
Read MorePR Newswire GENEVA and AMSTERDAM, Dec. 11, 2024 GENEVA and AMSTERDAM, Dec. 11, 2024 /PRNewswire/ -- iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, today provides a clinical update on its ...
Read MorePR Newswire SHANGHAI, Dec. 11, 2024 Sunvozertinib, as a single agent, demonstrated promising antitumor activity and favorable safety profile in heavily pretreated patients with EGFR-mutated NSCLC who had developed resistance to EGFR TKI ...
Read MorePR Newswire KANAZAWA, Japan, Dec. 11, 2024 KANAZAWA, Japan, Dec. 11, 2024 /PRNewswire/ -- Researchers at Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have discovered how a protein called lamin A helps repair the protective ...
Read MorePR Newswire WASHINGTON, Dec. 11, 2024 WASHINGTON, Dec. 11, 2024 /PRNewswire/ -- Surgo Health, in partnership with Pivotal, a network of organizations founded by Melinda French Gates, and SHOWTIME/MTV Entertainment Studios, has launched the ...
Read MorePR Newswire DOVER, Del. and EPALINGES, Switzerland, Dec. 10, 2024 DOVER, Del. and EPALINGES, Switzerland, Dec. 10, 2024 /PRNewswire/ -- Pilatus Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan ...
Read MorePR Newswire LAS VEGAS, Dec. 10, 2024 LAS VEGAS, Dec. 10, 2024 /PRNewswire/ -- The veterinary vaccines market is experiencing robust growth driven by factors such as the rising prevalence of zoonotic diseases, increasing concerns about ...
Read MorePR Newswire NEW YORK, Dec. 10, 2024 NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Report with market evolution powered by AI - The global alzheimer's disease therapeutics market size is estimated to grow by USD 5.41 billion from 2024-2028, ...
Read MorePR Newswire PHILADELPHIA, Dec. 10, 2024 New Locations in Collegeville and Malvern Mark Entry into Pennsylvania Market PHILADELPHIA, Dec. 10, 2024 /PRNewswire/ -- Options Medical Weight Loss, the nation's premier medical weight loss ...
Read MorePR Newswire STOCKHOLM, Dec. 10, 2024 STOCKHOLM, Dec. 10, 2024 /PRNewswire/ -- Moberg Pharma AB (OMX: MOB) announces that MOB-015 (topical terbinafine) did not meet the primary endpoint in the phase 3 study using 8 weeks of daily dosing ...
Read MorePR Newswire LONG ISLAND, N.Y., Dec. 10, 2024 LONG ISLAND, N.Y., Dec. 10, 2024 /PRNewswire/ -- LifeVac, the original choking rescue device, has reached an extraordinary milestone: saving 2,000 children from choking emergencies. This ...
Read MorePR Newswire NEW YORK, Dec. 10, 2024 NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The global epinephrine autoinjector market size is estimated to grow by USD 2.44 billion from 2024-2028, according to ...
Read MorePR Newswire WASHINGTON, Dec. 10, 2024 "A" rating of co-testing is critical to ensure patient-provider choice and access WASHINGTON, Dec. 10, 2024 /PRNewswire/ -- Today, the U.S. Preventive Services Task Force (Task Force) issued new ...
Read MorePR Newswire FOUNTAIN VALLEY, Calif., Dec. 10, 2024 FOUNTAIN VALLEY, Calif., Dec. 10, 2024 /PRNewswire/ -- U.S. News & World Report, the global authority in hospital rankings and consumer advice, has named MemorialCare's Miller Children's & ...
Read MorePR Newswire NEW YORK, Dec. 10, 2024 The genotyping market in North America is expected to grow from US$ 11,734.10 million in 2022 to US$ 37,599.28 million by 2028. It is estimated to grow at a CAGR of 21.4% from 2022 to 2028. NEW YORK, ...
Read MorePR Newswire LEWES, Del., Dec. 10, 2024 The peptide synthesis market is witnessing robust growth, fueled by increasing demand for peptide-based drugs in treating chronic diseases like cancer and diabetes. Advancements in synthesis ...
Read MorePR Newswire DELRAY BEACH, Fla., Dec. 10, 2024 DELRAY BEACH, Fla., Dec. 10, 2024 /PRNewswire/ -- The global Minimal Residual Disease market is expected to grow to USD 2.55 Billion by 2029, up from USD 1.43 Billion in 2024, at a CAGR of 12.2% ...
Read MorePR Newswire SAN DIEGO, Dec. 10, 2024 Patients on tafasitamab had a 57% improvement in progression-free survival compared to the control arm LBA-1: Tafasitamab Plus Lenalidomide and Rituximab for Relapsed or Refractory Follicular ...
Read MorePR Newswire SAN DIEGO, Dec. 10, 2024 Variants could serve as biomarker to inform prognosis or guide treatment decisions LBA-4: Andean Enriched NFKB1 Haplotype Reduces Inflammation and Improves Response to Ropeginterferon Alfa-2b in ...
Read MorePR Newswire SAN DIEGO, Dec. 10, 2024 Transplant shows no difference in overall or progression-free survival compared with maintenance therapy alone LBA-6: Lack of Benefit of Autologous Hematopoietic Cell Transplantation (auto-HCT) in ...
Read MorePR Newswire SAN DIEGO, Dec. 10, 2024 Transplant recipients show better physical, school, and social functioning than those receiving transfusions and medications alone LBA-5: Outcome of Cerebral Vasculopathy and Cognitive Performances 10 ...
Read MorePR Newswire SANTA ANA, Calif., Dec. 10, 2024 NAF calls for increased awareness and advocacy around use of AI to prevent potential abuses SANTA ANA, Calif., Dec. 10, 2024 /PRNewswire/ -- The Neuropathy Action Foundation (NAF), a ...
Read MorePR Newswire NANJING, China and GAITHERSBURG, Md., Dec. 10, 2024 NANJING, China and GAITHERSBURG, Md., Dec. 10, 2024 /PRNewswire/ -- TransThera Sciences (Nanjing), Inc. (the "TransThera"), a clinical demand-oriented, registrational clinical ...
Read MorePR Newswire NEW YORK, Dec. 10, 2024 In Memory of Dr. James Ledwith NEW YORK, Dec. 10, 2024 /PRNewswire/ -- AEYE Health , the leader in artificial intelligence-based diagnostics for retinal imaging, and UMass Memorial Health (UMMH), the ...
Read MorePR Newswire EAST HANOVER, N.J., Dec. 10, 2024 EAST HANOVER, N.J., Dec. 10, 2024 /PRNewswire/ -- Novartis today announced results from an updated analysis of the pivotal Phase III NATALEE trial of Kisqali® (ribociclib) that underscore the ...
Read MorePR Newswire SAN DIEGO, Dec. 10, 2024 SAN DIEGO, Dec. 10, 2024 /PRNewswire/ -- Vascarta Inc. ("Vascarta") reported new research findings at the 66th Annual American Society of Hematology meeting in San Diego showing that their novel ...
Read MorePR Newswire ALAMEDA, Calif., Dec. 10, 2024 The two companies will develop a test for feline influenza, calicivirus and herpes virus-1 that provides accurate results in minutes at point of need ALAMEDA, Calif., Dec. 10, 2024 /PRNewswire/ ...
Read MorePR Newswire SAN ANTONIO, Dec. 10, 2024 Expansion Brings New Principal Investigators, Expanded Site Resources, and Accelerated Trial Initiation to Support Breakthrough Blood Cancer Therapies SAN ANTONIO, Dec. 10, 2024 /PRNewswire/ -- The ...
Read MorePR Newswire FREDERICK, Md., Dec. 10, 2024 FREDERICK, Md., Dec. 10, 2024 /PRNewswire/ -- Theradaptive, a privately held, clinical stage biologics company developing protein therapeutics for spine, orthopedics, soft tissue repair, and targeted ...
Read MoreSubscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers